PerkinElmer's portfolio provides disease researchers the tools that enable insights and interactions between cell types and organ systems that lead to breakthroughs in prevention, early detection and treatment of diseases.
Infectious diseases continue to take a toll on human health, affecting all aspects of our lives. Fast development of preventative vaccines and therapeutic treat ...
Many prominent scientists, philosophers, and artists alike are mesmerized by the brain, likening this 3 lbs of matter to a computer, a great factory, a beautifu ...
Achieve greater visibility into the mechanisms that cause cardiovascular disease using our phenotypic and target-based solutions. We offer a broad range of prod ...
Detect disease-causing microbes, and detect and quantitate biomarkers of infectious disease, with our wide range of in vivo, in situ, cellular, and biochemical ...
Detect disease-causing microbes and quantitate biomarkers of inflammation with our wide range of in vivo, cellular, in situ, and biochemical research products. ...
Study targets of metabolic disease in vitro, in vivo and in situ using our biomarker detection kits, imaging systems and target-specific radiolabeled ligands, c ...
Biomarker detection has become an integral part of both disease detection and treatment. The detection of biomarkers in pre-symptomatic patients leads to the ab ...
Cytokines play a critical role in inflammation and immune response, and so are critical targets for many therapeutic areas. PerkinElmer offers a range of soluti ...
Protein kinases are key focus targets in drug discovery. Kinases regulate most cellular pathways and are responsible for the modification of nearly a third of a ...
Protein-protein interaction research is uncovering new targets for drug discovery in cancer and a variety of other diseases. However, measurement, modulation, a ...
The study of gene expression is opening new doors for drug discovery. Our epigenetics solutions include cellular detection kits and epigenetic assays for reader ...
G-protein coupled receptors (GPCR) are prominent targets in drug discovery. GPCRs are involved in most cellular responses to hormones and neurotransmitters and ...
